1. Home
  2. WST vs AEE Comparison

WST vs AEE Comparison

Compare WST & AEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • AEE
  • Stock Information
  • Founded
  • WST 1923
  • AEE 1901
  • Country
  • WST United States
  • AEE United States
  • Employees
  • WST N/A
  • AEE N/A
  • Industry
  • WST Medical/Dental Instruments
  • AEE Power Generation
  • Sector
  • WST Health Care
  • AEE Utilities
  • Exchange
  • WST Nasdaq
  • AEE Nasdaq
  • Market Cap
  • WST 15.6B
  • AEE 25.7B
  • IPO Year
  • WST N/A
  • AEE N/A
  • Fundamental
  • Price
  • WST $221.34
  • AEE $95.48
  • Analyst Decision
  • WST Buy
  • AEE Buy
  • Analyst Count
  • WST 7
  • AEE 11
  • Target Price
  • WST $331.67
  • AEE $101.27
  • AVG Volume (30 Days)
  • WST 693.0K
  • AEE 1.8M
  • Earning Date
  • WST 07-24-2025
  • AEE 07-31-2025
  • Dividend Yield
  • WST 0.38%
  • AEE 2.95%
  • EPS Growth
  • WST N/A
  • AEE 3.54
  • EPS
  • WST 6.37
  • AEE 4.51
  • Revenue
  • WST $2,895,800,000.00
  • AEE $7,596,000,000.00
  • Revenue This Year
  • WST $3.38
  • AEE $12.63
  • Revenue Next Year
  • WST $5.85
  • AEE $5.26
  • P/E Ratio
  • WST $34.66
  • AEE $21.38
  • Revenue Growth
  • WST N/A
  • AEE 9.04
  • 52 Week Low
  • WST $187.43
  • AEE $70.15
  • 52 Week High
  • WST $352.33
  • AEE $104.10
  • Technical
  • Relative Strength Index (RSI)
  • WST 54.22
  • AEE 47.06
  • Support Level
  • WST $215.67
  • AEE $95.02
  • Resistance Level
  • WST $226.80
  • AEE $96.71
  • Average True Range (ATR)
  • WST 5.24
  • AEE 1.40
  • MACD
  • WST -0.13
  • AEE 0.12
  • Stochastic Oscillator
  • WST 58.92
  • AEE 50.38

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About AEE Ameren Corporation

Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers.

Share on Social Networks: